In Vitro and In Vivo Drug-Response Profiling Using Patient-Derived High-Grade Glioma

SIMPLE SUMMARY: To date, personalized and comprehensive approaches to combat treatment resistances and failures are limited due to the highly heterogeneous, resistive, and invasive phenotype of GBM tumors. We present an integrative genomic, in vitro, and in vivo functional treatment paradigm for GBM...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajan, Robin G., Fernandez-Vega, Virneliz, Sperry, Jantzen, Nakashima, Jonathan, Do, Long H., Andrews, Warren, Boca, Simina, Islam, Rezwanul, Chowdhary, Sajeel A., Seldin, Jan, Souza, Glauco R., Scampavia, Louis, Hanafy, Khalid A., Vrionis, Frank D., Spicer, Timothy P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339991/
https://www.ncbi.nlm.nih.gov/pubmed/37444398
http://dx.doi.org/10.3390/cancers15133289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339991/
https://www.ncbi.nlm.nih.gov/pubmed/37444398
http://dx.doi.org/10.3390/cancers15133289

Ejemplares similares